Skip to main content

previous disabled Page of 4
and
  1. No Access

    Article

    Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-α antibody

    The role of tumor necrosis factor-α in the shedding of soluble tumor necrosis factor receptors in endotoxemia was investigated. The appearance of the soluble tumor necrosis factor receptors was assessed in four h...

    Jaap Jansen, Tom van der Poll, Marcel Levi, Hugo ten Cate in Journal of Clinical Immunology (1995)

  2. No Access

    Article

    Acute hepatitis in a patient using a Chinese herbal tea ‐ a case report.

    A case is presented of reversible acute hepatitis in a patient using a Chinese herbal tea. Upon identification of the tea mixture Aristolochia species, including A. debilis, which contains the highly toxic ari...

    Marcel Levi, Henk‐Jan Guchelaar, Herman J. Woerdenbag in Pharmacy World and Science (1998)

  3. No Access

    Article

    Current Drug Treatment Strategies for Disseminated Intravascular Coagulation

    Disseminated intravascular coagulation (DIC) can be caused by a variety of diseases. Experimental models of DIC have provided substantial insight into the pathogenesis of this disorder, which may ultimately re...

    Dr Evert de Jonge, Marcel Levi, Christiaan P. Stoutenbeek in Drugs (1998)

  4. No Access

    Article

    Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits

    Severe thrombocytopenia frequently occurs in patients receiving chemotherapy and in patients with autoimmune disorders. Thrombocytopenia is associated with bleeding, which may be serious and life threatening1,2,3

    Marcel Levi, Philip W. Friederich, Sarah Middleton, Philip G. de Groot in Nature Medicine (1999)

  5. No Access

    Article

    Pathogenesis of DIC in Sepsis

    Sepsis can be associated with profound alterations in the hemostatic mechanism. In this article we discuss recent insights into which mediators are involved in the activation of the coagulation system. We focu...

    Tom van der Poll, Evert de Jonge, Marcel Levi, Sander J.H. van Deventer in Sepsis (1999)

  6. No Access

    Article

    Relative Insufficiency of the Fibrinolytic System in Disseminated Intravascular Coagulation

    Experimental and clinical observations indicate that the systemic deposition of fibrin in disseminated intravascular coagulation (DIC) is insufficiently counteracted by endogenous fibrinolysis. In fact, a mark...

    Marcel Levi, Tom van der Poll, Evert de Jonge, Hugo ten Cate in Sepsis (1999)

  7. No Access

    Article

    Mouse models of focal arterial and venous thrombosis

    Mouse models of arterial and venous thrombosis have gained increasing interest over the last 15 years, due to direct availability of a growing number of genetically modified mice, improved technical feasibili...

    Janine Dörffler-Melly, Lothar A. Schwarte, Can Ince in Basic Research in Cardiology (2000)

  8. No Access

    Chapter

    Hemostasis and Coagulation

    Bleeding is one of the major complications of surgery. Serious intraoperative and postoperative bleeding may be caused by a local problem in surgical hemostasis, such as a failed ligature, but can also be caus...

    Marcel Levi, Tom van der Poll in Surgery (2001)

  9. No Access

    Chapter

    Coagulation and Fibrinolysis During Endotoxemia and Gram-Negative Sepsis

    Severe gram-negative infections are sometimes associated with the clinical syndrome of disseminated intravascular coagulation (DIC). The derangement of the hemostatic mechanism not only comprises enhanced acti...

    Tom Van Der Poll, Marcel Levi, Sander J. H. Van Deventer in Physiology of Inflammation (2001)

  10. No Access

    Article

    Drotrecogin Alfa (Activated)

    Marcel Levi in Drugs (2002)

  11. No Access

    Chapter

    Hemostasis and Coagulation

    Marcel Levi, Tom van der Poll in Essential Practice of Surgery (2003)

  12. No Access

    Article

    Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis

    Anne Cornélie J. M. de Pont, Catherine S. C. Bouman in Intensive Care Medicine (2003)

  13. No Access

    Article

    Sepsis and Disseminated Intravascular Coagulation

    Sepsis almost invariably leads to hemostatic abnormalities, ranging from insignificant laboratory changes to severe disseminated intravascular coagulation (DIC). There is compelling evidence from clinical and ...

    Marcel Levi, Evert de Jonge, Tom van der Poll in Journal of Thrombosis and Thrombolysis (2003)

  14. No Access

    Article

    Prevention and Treatment of Bleeding by Pro-hemostatic Treatment Strategies

    Pro-hemostatic therapy may achieve an improvement of hemostasis, by amelioration of primary hemostasis, stimulation of fibrin formation or inhibition of fibrinolysis. Pro-hemostatic interventions appear to be ...

    Marcel Levi, Roel Vink, Evert de Jonge in Wiener Medizinische Wochenschrift (2003)

  15. Article

    Coagulation in sepsis: all bugs bite equally

    Sepsis almost invariably leads to hemostatic abnormalities, ranging from insignificant laboratory changes to severe disseminated intravascular coagulation. There is compelling evidence from clinical and experi...

    Marcel Levi, Tom van der Poll in Critical Care (2004)

  16. Article

    Open Access

    Factors that predict outcome of intensive care treatment in very elderly patients: a review

    Advanced age is thought to be associated with increased mortality in critically ill patients. This report reviews available data on factors that determine outcome, on the value of prognostic models, and on pre...

    Sophia E de Rooij, Ameen Abu-Hanna, Marcel Levi, Evert de Jonge in Critical Care (2005)

  17. Article

    Open Access

    Recombinant human activated protein C resets thrombin generation in patients with severe sepsis – a case control study

    Recombinant human activated protein C (rhAPC) is the first drug for which a reduction of mortality in severe sepsis has been demonstrated. However, the mechanism by which this reduction in mortality is achieve...

    Anne-Cornélie JM de Pont, Kamran Bakhtiari, Barbara A Hutten in Critical Care (2005)

  18. Article

    Antithrombin in sepsis revisited

    As the pivotal phase III randomized controlled clinical trial on antithrombin concentrate in patients with severe sepsis did not show a beneficial effect of antithrombin treatment on 28-day mortality, the inte...

    Marcel Levi in Critical Care (2005)

  19. No Access

    Article

    Prescription of rh-APC differs substantially among western European countries

    Marcus J. Schultz, Marcel Levi in Intensive Care Medicine (2006)

  20. Article

    Coagulation abnormalities in critically ill patients

    Many critically ill patients develop hemostatic abnormalities, ranging from isolated thrombocytopenia or prolonged global clotting tests to complex defects, such as disseminated intravascular coagulation. Ther...

    Marcel Levi, Steven M Opal in Critical Care (2006)

previous disabled Page of 4